DE60027176D1 - Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1 - Google Patents

Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1

Info

Publication number
DE60027176D1
DE60027176D1 DE60027176T DE60027176T DE60027176D1 DE 60027176 D1 DE60027176 D1 DE 60027176D1 DE 60027176 T DE60027176 T DE 60027176T DE 60027176 T DE60027176 T DE 60027176T DE 60027176 D1 DE60027176 D1 DE 60027176D1
Authority
DE
Germany
Prior art keywords
psa
igf
prostate cancer
proof
relationship
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60027176T
Other languages
English (en)
Other versions
DE60027176T2 (de
Inventor
Keith Griffiths
Atilla T Turkes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JOKEN Ltd
Original Assignee
JOKEN Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9923599.6A external-priority patent/GB9923599D0/en
Priority claimed from GB0012869A external-priority patent/GB0012869D0/en
Application filed by JOKEN Ltd filed Critical JOKEN Ltd
Publication of DE60027176D1 publication Critical patent/DE60027176D1/de
Application granted granted Critical
Publication of DE60027176T2 publication Critical patent/DE60027176T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
DE60027176T 1999-10-07 2000-10-09 Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1 Expired - Fee Related DE60027176T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9923599.6A GB9923599D0 (en) 1999-10-07 1999-10-07 Assay
GB9923599 1999-10-07
GB0012869 2000-05-27
GB0012869A GB0012869D0 (en) 2000-05-27 2000-05-27 Assay
PCT/GB2000/003854 WO2001025790A1 (en) 1999-10-07 2000-10-09 Detection of prostate cancer measuring psa/igf-1 ratio

Publications (2)

Publication Number Publication Date
DE60027176D1 true DE60027176D1 (de) 2006-05-18
DE60027176T2 DE60027176T2 (de) 2007-03-08

Family

ID=26244366

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60027176T Expired - Fee Related DE60027176T2 (de) 1999-10-07 2000-10-09 Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1

Country Status (8)

Country Link
EP (1) EP1218749B1 (de)
AT (1) ATE322687T1 (de)
AU (1) AU781669B2 (de)
CA (1) CA2388706A1 (de)
DE (1) DE60027176T2 (de)
ES (1) ES2259290T3 (de)
PT (1) PT1218749E (de)
WO (1) WO2001025790A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401476A4 (de) 2001-03-14 2006-03-08 Genentech Inc Igf-antagonistenpeptide
GB0503741D0 (en) * 2005-02-23 2005-03-30 Eden Research Plc Assay
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
EP2757731B1 (de) 2013-01-21 2015-02-18 Fujitsu Limited Drahtloses MIMO-Kommunikationssystem
CN106932570A (zh) * 2017-03-07 2017-07-07 中国人民解放军第二军医大学 一种检测前列腺特异性抗原psa的试剂盒及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
CA2319252C (en) * 1998-01-21 2004-11-30 Brigham And Women's Hospital, Inc. Circulating insulin-like growth factor-i and prostate cancer risk

Also Published As

Publication number Publication date
ES2259290T3 (es) 2006-10-01
EP1218749B1 (de) 2006-04-05
DE60027176T2 (de) 2007-03-08
EP1218749A1 (de) 2002-07-03
ATE322687T1 (de) 2006-04-15
WO2001025790A1 (en) 2001-04-12
PT1218749E (pt) 2006-08-31
AU781669B2 (en) 2005-06-02
AU7673600A (en) 2001-05-10
CA2388706A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
SE0000538D0 (sv) Methods and kits for proximity probing
NO20025371L (no) Forbedringer til fluorescense polymer-QTL tiln¶rming til biodetektering
ATE226729T1 (de) Quantitative immunochromatographische assays
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
CA2214488A1 (en) Determination of cpsa
DE69840146D1 (de) Fluoreszenzprotein-sensoren zur erkennung von analyten
DE50115064D1 (de) Sensor zur lumineszenz-optischen bestimmung eines analyten
ATE384952T1 (de) Enzymhemmungsimmunverfahren
WO2002016943A3 (en) Differential immunoassay
DE60027176D1 (de) Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1
CA2361000A1 (en) Urinary trypsin inhibitor to diagnose aids
EP1138781A3 (de) Methode zur Quantifizierung der Bindeaktivität von DNA-bindenden Proteinen
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
CA2434694A1 (en) Detection and quantification of cripto-1
EP1441224A3 (de) Enzymhemmungsimmunverfahren
WO2001084161A3 (en) Process for the measurement of non-transferrin bound iron
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
BR9913770A (pt) Processo de ensaio para determinação da cobalamina ligada a transcobalamina ii (tcii) em uma amostra de corpo, kit para uso em um ensaio diagnóstico, e, uso de holo-tc ii
TR200100643T2 (tr) Yüksek-çekimli antikorlar
ATE292283T1 (de) Verfahren zur immobilisierung von affinen reagentien an hydrophoben festphasen
WO2002004122A3 (en) Improved stability of hybridisation interactions in dipstick assays
EP1636587A4 (de) Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose
CA2375503A1 (en) An assay for the determination of newly synthesised antibodies in lymphocytes
EP2105741A3 (de) Verwendung eines einen Bindungsteil exprimierenden Virus zur Messung von Analyten in einer Probe
DE69917378D1 (de) Methylorange verwendende spezifische bindungsassays

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee